5 Best Biotech Penny Stocks to Invest In
Ocean Biomedical, Inc. (NASDAQ:OCEA) is a biopharmaceutical company that focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases.
Vbi Vaccines Inc (VBIV)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 0 | $0 | -100% | 0% |
| 2. | 0 | $0 | -100% | 0% | |
| 3. | Alyeska Investment Group Anand Parekh | 0 | $0 | -100% | 0% |
| 4. | Citadel Investment Group Ken Griffin | 0 | $0 | -100% | 0% |
| 5. | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.65 | 609,090 | Director | 1,043,292 | 2023-07-10 | Filing | |
| $2.45 | 8,200 | Officer | 68,200 | 2021-12-03 | Filing | |
| $1.10 | 9,090,909 | Large Shareholder | 55,042,456 | 2020-04-24 | Filing | |
| $0.50 | 40,000 | Officer | 117,500 | 2019-10-04 | Filing | |
| $0.50 | 14,500 | Officer | 14,500 | 2019-09-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.11 | 4,251,563 | Large Shareholder | 41,440,729 | 2023-04-06 | Filing | |
| $0.13 | 1,832,563 | Large Shareholder | 45,691,816 | 2023-04-05 | Filing | |
| $0.16 | 4,810,623 | Large Shareholder | 47,524,379 | 2023-04-04 | Filing | |
| $3.31 | 2,707,463 | Large Shareholder | 52,334,993 | 2021-12-01 | Filing | |
| $4.00 | 320,388 | Large Shareholder | 145,548 | 2021-06-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 184,436 | $108,356 | 0% | |
| 2. | 138,729 | $81,525 | 0% | |
| 3. | 117,700 | $68,943 | 0% | |
| 4. | 111,960 | $65,776 | 0% | |
| 5. | 32,992 | $19,383 | 0% |
News See All
Hedge Fund and Insider Trading News: Bill Ackman, Steven Cohen, Warren Buffett, Alden Global Capital, PAC Capital, Sagimet Biosciences (SGMT), Muscle Maker, Inc. (GRIL), and More
Bill Ackman’s Pershing Square Capital Management recorded an 8.8% loss of its net asset value (NAV) last year, according to Morningstar data.
10 Best Biotech Stocks to Buy According to Joseph Edelman’s Perceptive Advisors
In this article, we will discuss the 10 best biotech stocks to buy according to Joseph Edelman’s Perceptive Advisors.
Hedge Funds Are Buying VBI Vaccines, Inc. (VBIV)
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
10 Best Biotech Penny Stocks to Buy Now
The scintillating pace of technological advancement in the world over the past few decades has transformed the fortunes of the human race, freeing up important time for some of the top scientific minds...
Is VBIV A Good Stock To Buy Now?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is VBI Vaccines, Inc. (VBIV) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Have Never Been This Bullish On VBI Vaccines, Inc. (VBIV)
Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse of whether that stock could make for a good addition...
Hedge Fund and Insider Trading News: Sahm Adrangi, Bernard Selz, Stryker Corporation (SYK), VBI Vaccines Inc (VBIV), and More
Kerrisdale Capital, the US hedge fund that made a public enemy of Neil Woodford after shorting two of his prominent holdings, is no longer making bets against companies backed by the embattled UK stock...
13D Filing: Perceptive Advisors Keeps Funding Vbi Vaccines Inc
required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that...